Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +1.4% | ▲ +5.0% | ▲ +25.0% | ▲ +35.7% | ▲ +45.3% | ▲ +73.4% | ▲ +33.0% | ▲ +699.3% |
| Peer average | ▲ +1.2% | ▲ +4.5% | ▲ +9.5% | ▲ +22.6% | ▲ +30.8% | ▲ +76.1% | ▲ +30.8% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2025-12-22 | 2025-12-26 | $0.96 |
| 2024-12-23 | 2024-12-24 | $1.25 |
| 2023-12-18 | 2023-12-22 | $0.71 |
| 2022-12-19 | 2022-12-23 | $0.75 |
| 2021-12-20 | 2021-12-27 | $0.40 |
| 2020-12-21 | 2020-12-28 | $0.61 |
| 2019-12-23 | 2019-12-30 | $0.47 |
| 2018-12-20 | 2018-12-27 | $0.55 |
| 2017-12-18 | 2017-12-22 | $0.68 |
| 2016-12-19 | 2016-12-23 | $0.33 |
| 2015-12-21 | 2015-12-28 | $0.34 |
| 2013-12-23 | 2013-12-30 | $0.00 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind BBH.